Article Details

Biopharma Study Shows Safety of Stem Cell Therapy in Severe COVID-19 Patients

Retrieved on: 2021-04-28 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Study Shows Safety of Stem Cell Therapy in Severe COVID-19 Patients. View article details on hiswai:

Excerpt

Once all Phase 1b data are available, the biopharma, with guidance from the U.S. Food and Drug Administration, will plan the subsequent trial.

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up